Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion

Healthy guts exclude oxygen Normally, the lumen of the colon lacks oxygen. Fastidiously anaerobic butyrate-producing bacteria thrive in the colon; by ablating these organisms, antibiotic treatment removes butyrate. Byndloss et al. discovered that loss of butyrate deranges metabolic signaling in gut cells (see the Perspective by Cani). This induces nitric oxidase to generate nitrate in the lumen and disables β-oxidation in epithelial cells that would otherwise mop up stray oxygen before it enters the colon. Simultaneously, regulatory T cells retreat, and inflammation is unchecked, which contributes yet more oxygen species to the colon. Then, facultative aerobic pathogens, such as Escherichia coli and Salmonella enterica, can take advantage of the altered environment and outgrow any antibiotic-crippled and benign anaerobes. Science, this issue p. 570; see also p. 548 Butyrate-producing microbes contribute to synergism between epithelial cell metabolism and immune response regulation to maintain gut heath. Perturbation of the gut-associated microbial community may underlie many human illnesses, but the mechanisms that maintain homeostasis are poorly understood. We found that the depletion of butyrate-producing microbes by antibiotic treatment reduced epithelial signaling through the intracellular butyrate sensor peroxisome proliferator–activated receptor γ (PPAR-γ). Nitrate levels increased in the colonic lumen because epithelial expression of Nos2, the gene encoding inducible nitric oxide synthase, was elevated in the absence of PPAR-γ signaling. Microbiota-induced PPAR-γ signaling also limits the luminal bioavailability of oxygen by driving the energy metabolism of colonic epithelial cells (colonocytes) toward β-oxidation. Therefore, microbiota-activated PPAR-γ signaling is a homeostatic pathway that prevents a dysbiotic expansion of potentially pathogenic Escherichia and Salmonella by reducing the bioavailability of respiratory electron acceptors to Enterobacteriaceae in the lumen of the colon.

[1]  Fabian Rivera-Chávez,et al.  Energy Taxis toward Host-Derived Nitrate Supports a Salmonella Pathogenicity Island 1-Independent Mechanism of Invasion , 2016, mBio.

[2]  C. Lebrilla,et al.  Depletion of Butyrate-Producing Clostridia from the Gut Microbiota Drives an Aerobic Luminal Expansion of Salmonella. , 2016, Cell host & microbe.

[3]  Na-Ri Shin,et al.  Proteobacteria: microbial signature of dysbiosis in gut microbiota. , 2015, Trends in biotechnology.

[4]  T. Weir,et al.  Crosstalk between Microbiota-Derived Short-Chain Fatty Acids and Intestinal Epithelial HIF Augments Tissue Barrier Function. , 2015, Cell host & microbe.

[5]  J. Tiedje,et al.  Revealing the Bacterial Butyrate Synthesis Pathways by Analyzing (Meta)genomic Data , 2014, mBio.

[6]  M. Hattori,et al.  Characterization of the 17 strains of regulatory T cell-inducing human-derived Clostridia , 2014, Gut microbes.

[7]  Michael D. George,et al.  The cytokine IL-22 promotes pathogen colonization by suppressing related commensal bacteria. , 2014, Immunity.

[8]  Huidong Shi,et al.  Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. , 2014, Immunity.

[9]  R. Medzhitov,et al.  The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition , 2014, Proceedings of the National Academy of Sciences.

[10]  M. Tomita,et al.  Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells , 2013, Nature.

[11]  A. Rudensky,et al.  Metabolites produced by commensal bacteria promote peripheral regulatory T cell generation , 2013, Nature.

[12]  P. Luciw,et al.  PPARγ-mediated increase in glucose availability sustains chronic Brucella abortus infection in alternatively activated macrophages. , 2013, Cell host & microbe.

[13]  W. Garrett,et al.  The Microbial Metabolites, Short-Chain Fatty Acids, Regulate Colonic Treg Cell Homeostasis , 2013, Science.

[14]  M. Hattori,et al.  Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota , 2013, Nature.

[15]  S. Winter,et al.  Streptomycin-Induced Inflammation Enhances Escherichia coli Gut Colonization Through Nitrate Respiration , 2013, mBio.

[16]  Paul J. McMurdie,et al.  phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data , 2013, PloS one.

[17]  Sanjai J. Parikh,et al.  Host-Derived Nitrate Boosts Growth of E. coli in the Inflamed Gut , 2013, Science.

[18]  Anders K. Haakonsson,et al.  Short-Chain Fatty Acids Stimulate Angiopoietin-Like 4 Synthesis in Human Colon Adenocarcinoma Cells by Activating Peroxisome Proliferator-Activated Receptor γ , 2013, Molecular and Cellular Biology.

[19]  S. Winter,et al.  Early MyD88-Dependent Induction of Interleukin-17A Expression during Salmonella Colitis , 2011, Infection and Immunity.

[20]  Wei Sun,et al.  The microbiome and butyrate regulate energy metabolism and autophagy in the mammalian colon. , 2011, Cell metabolism.

[21]  Deyu Li,et al.  A versatile valve-enabled microfluidic cell co-culture platform and demonstration of its applications to neurobiology and cancer biology , 2011, Biomedical microdevices.

[22]  K. Honda,et al.  Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species , 2011, Science.

[23]  M. Chamaillard,et al.  Peroxisome proliferator-activated receptor gamma activation is required for maintenance of innate antimicrobial immunity in the colon , 2010, Proceedings of the National Academy of Sciences.

[24]  Y. Setiady,et al.  In vivo depletion of CD4+FOXP3+ Treg cells by the PC61 anti‐CD25 monoclonal antibody is mediated by FcγRIII+ phagocytes , 2010, European journal of immunology.

[25]  R. Xavier,et al.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43 , 2009, Nature.

[26]  S. Kizaka-Kondoh,et al.  Significance of nitroimidazole compounds and hypoxia‐inducible factor‐1 for imaging tumor hypoxia , 2009, Cancer science.

[27]  Harry J. Flint,et al.  Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. , 2009, FEMS microbiology letters.

[28]  R. Playford,et al.  Comparison of cytokine modulation by natural peroxisome proliferator-activated receptor gamma ligands with synthetic ligands in intestinal-like Caco-2 cells and human dendritic cells--potential for dietary modulation of peroxisome proliferator-activated receptor gamma in intestinal inflammation. , 2008, The American journal of clinical nutrition.

[29]  S. Saitoh,et al.  Immunohistochemical detection of hypoxia in mouse liver tissues treated with pimonidazole using “in vivo cryotechnique” , 2007, Histochemistry and Cell Biology.

[30]  P. Jeannesson,et al.  Butyrate affects differentiation, maturation and function of human monocyte‐derived dendritic cells and macrophages , 2002, Clinical and experimental immunology.

[31]  A. Barrientos In vivo and in organello assessment of OXPHOS activities. , 2002, Methods.

[32]  R. Hershberg,et al.  Hypoxia-Inducible Factor 1–Dependent Induction of Intestinal Trefoil Factor Protects Barrier Function during Hypoxia , 2001, The Journal of experimental medicine.

[33]  C. Datz,et al.  Peroxisome proliferator-activated receptor gamma is induced during differentiation of colon epithelium cells. , 1999, The Journal of endocrinology.

[34]  A. Morinobu,et al.  Butyrate inhibits functional differentiation of human monocyte-derived dendritic cells. , 2008, Cellular immunology.